Unique ID issued by UMIN | UMIN000038357 |
---|---|
Receipt number | R000043712 |
Scientific Title | Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer:exploratory clinical trial |
Date of disclosure of the study information | 2019/10/23 |
Last modified on | 2025/04/26 14:55:55 |
Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer:exploratory clinical trial
Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer (SPEC trial)
Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer:exploratory clinical trial
Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer (SPEC trial)
Japan |
gastric cancer
Gastroenterology |
Malignancy
NO
To evaluate efficacy and safety of additional S-1 therapy for patients underwent non curative gastric ESD who refuse additional gastrectomy.
Safety,Efficacy
Exploratory
Pragmatic
Relapse-free survival
overall survival, Disease specific survival, Rate of treatment continuation, Adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
8 courses of S-1 chemotherapy
20 | years-old | <= |
85 | years-old | >= |
Male and Female
1) Patients underwent non curative ESD for gastric cancer who refuse additional gastrectomy
2) Age from 20 to 85 years old
3) European Cooperative Oncology Group(ECOG) performance status of 0 or 1
4) No previous treatment of chemotherapy or radiation therapy for any neoplasms
5) Enough oral intake
6) Preserved organ function as follows
1 neutrophile count >=1,500/mm3
2 hemoglobin >=8.0 g/dL
3 platelet count >=75,000/mm3
4 AST=<100 IU/L
5 ALT=<100 IU/L
6 total bilirubin =<2.0 mg/dL
7 creatinine clearance (CCr) >=40 mL/min
7) Written informed consent
1)Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 5 years or shoter, except mucosal cancer treated by endoscopic resection
2) previous gastrectomy
3) Infection requiring systemic treatment
4) Women expecting pregnancy, in pregnancy, in possible pregnancy or in breast feeding
5) Male expecting partner's pregnancy
6) Severe mental disease
7) Under treatment by flucytosine, phenytoin, or warfarin potassium
8) Uncontrolled diabetes mellitus
9) severe lung disease (Interstitial pneumonia, severe emphysema and so on)
10) unstable angina or myocardial infarction within 6 months
30
1st name | Hiroaki |
Middle name | |
Last name | Sawai |
Takatsuki general hospital
Division of Gastroenterology
569-1192
1-3-13 Kosobe-cho, Takatsuki-city
072-681-3801
shiroaki23@gmail.com
1st name | Hiroaki |
Middle name | |
Last name | Sawai |
Takatsuki general hospital
Division of Gastroenterology
569-1192
1-3-13 Kosobe-cho, Takatsuki-city
072-681-3801
shiroaki23@gmail.com
Takatsuki general hospital
Takatsuki general hospital
Other
Graduate School of Medicine, Kyoto University
Japanese Red Cross Wakayama Medical Center
Kobe City Medical Center General Hospital
Hyogo Cancer Center
Gastrointestinal Center, SANO HOSPITAL
Akashi Medical Association Akashi Medical Center
Ise Red Cross Hospital
Kobe University Hospital
Takatsuki general hospital
1-3-13 Kosobe-cho, Takatsuki-city
072-681-3801
yuge.junko@aijinkai-group.com
NO
2019 | Year | 10 | Month | 23 | Day |
Unpublished
9
No longer recruiting
2019 | Year | 10 | Month | 11 | Day |
2019 | Year | 10 | Month | 11 | Day |
2019 | Year | 10 | Month | 25 | Day |
2026 | Year | 09 | Month | 30 | Day |
2019 | Year | 10 | Month | 22 | Day |
2025 | Year | 04 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043712